[System valid from October 1, 2023 until March 31, 2024]
Public expense subsidy (when receiving outpatient coronavirus treatment)
Part of the costs of the following high-cost medicines prescribed for the treatment of coronavirus infection will be covered by public funds.
- Oral medicines “Lagebrio”, “Paxlovid” and “Xocova”.
- Intravenous medications ” Vecluri “.
- Neutralizing antibody medications “Zebudi”, “Lonaprieve” and “Evusheld”.
* Other medical fees, prescription fees, medication fees and other procedure fees are not covered by public spending.
Details of the subsidy to cover part of the costs of medicines
The amount that must be paid by the patient is determined according to the rate for medical expenses.
The amount is 9,000 yen (30%), 6,000 yen (20%), and 3,000 yen (10%).
Public funds are used so that the above values do not change.
Click here for information about public financing for hospitalization for coronavirus treatment.
